Primary mediastinal B-cell lymphoma · 4 regimens
Cost vs Efficacy · 2 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
DA-R-EPOCH Variant #01 | — | R 28 060 | 21d | — | — | ~8 | ~R 224 478 PFS proxy · indirect | 1 |
R-CHOP (Prednisolone) Variant #01 | — | R 26 953 | 21d | ~42.4 mo | — | ~3 | ~R 80 858 PFS proxy · indirect | — |
R-CHOP Variant #08 | — | R 26 946 | 21d | ~14.4 mo | ~55.7 mo | ~9 | ~R 242 515 PFS proxy · indirect | 11 |
R-CHOP-14 (Prednisolone) Variant #01 | — | R 26 789 | 14d | — | — | ~8 | ~R 212 546 PFS proxy · indirect | 1 |
4 of 4 regimens shown